JLKSX | RBEMX | JLKSX / RBEMX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 11 years | 10 years | - |
Gain YTD | 16.123 | 14.261 | 113% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 426M | 23.9B | 2% |
Annual Yield % from dividends | 1.74 | 0.76 | 228% |
Returns for 1 year | 23.26 | 21.18 | 110% |
Returns for 3 years | -12.36 | -2.56 | 482% |
Returns for 5 years | 17.17 | 32.68 | 53% |
Returns for 10 years | 38.13 | 64.98 | 59% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HWVIX | 13.60 | -0.08 | -0.58% |
Hotchkis & Wiley Sm Cp Divers Val I | |||
NMPAX | 16.01 | -0.17 | -1.05% |
Columbia Mid Cap Index Inst | |||
FNITX | 39.56 | -0.78 | -1.93% |
Fidelity Advisor New Insights M | |||
JBSOX | 24.62 | -0.51 | -2.03% |
JHancock New Opportunities C | |||
LYFCX | 12.76 | -0.29 | -2.22% |
AlphaCentric Life Sciences & Hlthcare C |